The drug development sector is embracing technologies and digital methods that were previously not as widely used due to the COVID-19 global health crisis.
Maria I. Florez
Advertisement
Articles by Maria I. Florez
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
Could DTC Programs Help Simplify the Drug-Pricing System?
3
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
4
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
5
